We are live on ! Find out more
ATXS

Astria Therapeutics
ATXS

Delisted

ATXS was delisted on the 22nd of January, 2026.

Back to rankings

0 hedge funds and large institutions have $0 invested in Astria Therapeutics in 2026 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 140 closing their positions.

New
Increased
Maintained
Reduced
Closed

99.02% less ownership

Funds ownership: 99.02% → 0% (-99%)

100% less funds holding

Funds holding: 141 → 0 (-141)

100% less capital invested

Capital invested by funds: $738M → $0 (-$738M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 140

Holders
–
Holders Change
-141
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
140
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$84.9M
2
BlackRock
BlackRock
New York
-$50.2M
3
GCL
Glazer Capital LLC
New York
-$49.4M
4
MF
Magnetar Financial
Illinois
-$44.9M
5
UBS Group
UBS Group
Switzerland
-$31.4M
Name Holding Trade Value Shares
Change 		Change in
Stake
RIL
126
Rothschild Investment LLC
Illinois
– -$1.5K -115 Closed
CA
127
Clearstead Advisors
Ohio
– -$1.32K -101 Closed
WAM
128
Wolverine Asset Management
Illinois
– -$1.31K -100 Closed
BWA
129
Basecamp Wealth Advisors
Washington
– -$1.27K -97 Closed
PFBT
130
Parkside Financial Bank & Trust
Missouri
– -$1.18K -90 Closed
CFM
131
Cornerstone Financial Management
Massachusetts
– -$1.02K -78 Closed
TM
132
Torren Management
California
– -$1.01K -77 Closed
US Bancorp
133
US Bancorp
Minnesota
– -$916 -70 Closed
KFI
134
Key Financial Inc
Pennsylvania
– -$864 -66 Closed
RWM
135
Rialto Wealth Management
New York
– -$524 -40 Closed
S
136
SignatureFD
Georgia
– -$262 -20 Closed
AAP
137
Arax Advisory Partners
Colorado
– -$92 -7 Closed
LFG
138
Larson Financial Group
Missouri
– -$92 -7 Closed
SPIA
139
Steward Partners Investment Advisory
New York
– -$39 -3 Closed
SS
140
SBI Securities
Japan
– -$13 -1 Closed
2 3 4 5
6

ATXS Hedge Fund Activity: Q1 2026 in Review

0 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Astria Therapeutics (ATXS) for Q1 2026, worth a combined $0 — down 100% from $738M a quarter earlier.

Sellers outnumbered buyers: 140 funds closed out of ATXS and 0 opened new positions — a net loss of 140 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Perceptive Advisors, exiting entirely with an estimated $84.9M sold.

  • 0 institutional investors held Astria Therapeutics (ATXS) as of Q1 2026, down from 141 in Q4 2025.
  • Funds reported $0 of Astria Therapeutics stock for Q1 2026, down 100% quarter-over-quarter.
  • 0 funds opened new Astria Therapeutics positions in Q1 2026 and 140 closed out, a net change of -140 holders.
  • The largest Astria Therapeutics seller in Q1 2026 was Perceptive Advisors, an estimated $84.9M sold.

Based on aggregated 13F filings for Q1 2026.